Carl Sterritt
Chief Executive Officer at Phosphate Therapeutics Ltd.
Carl Sterritt active positions
| Companies | Position | Start | End |
|---|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Chief Executive Officer | - | - |
Career history of Carl Sterritt
Former positions of Carl Sterritt
| Companies | Position | Start | End |
|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Director/Board Member | 01/01/2008 | 22/04/2020 |
| Chief Executive Officer | 01/01/2008 | 22/04/2020 | |
| Founder | 01/01/2008 | 22/04/2020 | |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01/01/2006 | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Director/Board Member | 02/06/2011 | 04/02/2015 |
| Chief Executive Officer | 02/06/2011 | - | |
| Chairman | - | - | |
| Founder | 01/01/2008 | - |
Statistics
International
| United Kingdom | 3 |
| United States | 3 |
| Switzerland | 2 |
Operational
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 6 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Carl Sterritt
- Experience
